Table 1.

 Observations supporting the testing of psychopharmacological agents for functional gastrointestinal disorders

▸ High lifetime and current rates of anxiety disorders and depression

▸ High self reported distress

▸ Increased sexual and physical abuse histories

▸ Response of other functional syndromes to antidepressants

▸ Response of neuropathic pain syndromes to antidepressants